(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane

C112H154ClF8N26O20S6ScSe- — CID 159427083

IUPAC(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane
SMILESC.C.C=CC(=O)Nc1cccc(Nc2nc(Cl)ncc2C(F)(F)F)c1.C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)OC[C@@H]3CN(C)CCN43)ncc2C(F)(F)F)c1.CC(C)(C)OC(=O)N1CCN2c3ccc([N+](=O)[O-])cc3OC[C@@H]2C1.CC(C)(C)OC(=O)N1CCN[C@H](CO)C1.CN1CCN2c3ccc(N)cc3OC[C@@H]2C1.CN1CCN2c3ccc([N+](=O)[O-])cc3OC[C@@H]2C1.CS.C[SeH].O=[N+]([O-])c1ccc(F)c(F)c1.O=[N+]([O-])c1ccc2c(c1)OC[C@@H]1CNCCN21.S.S.S.S.S.[CH3-].[Sc]
InChIInChI=1S/C26H26F3N7O2.C16H21N3O5.C14H10ClF3N4O.C12H15N3O3.C12H17N3O.C11H13N3O3.C10H20N2O3.C6H3F2NO2.CH4S.CH4Se.2CH4.CH3.5H2S.Sc/c1-3-23(37)31-16-5-4-6-17(11-16)32-24-20(26(27,28)29)13-30-25(34-24)33-18-7-8-21-22(12-18)38-15-19-14-35(2)9-10-36(19)21;1-16(2,3)24-15(20)17-6-7-18-12(9-17)10-23-14-8-11(19(21)22)4-5-13(14)18;1-2-11(23)20-8-4-3-5-9(6-8)21-12-10(14(16,17)18)7-19-13(15)22-12;1-13-4-5-14-10(7-13)8-18-12-6-9(15(16)17)2-3-11(12)14;1-14-4-5-15-10(7-14)8-16-12-6-9(13)2-3-11(12)15;15-14(16)8-1-2-10-11(5-8)17-7-9-6-12-3-4-13(9)10;1-10(2,3)15-9(14)12-5-4-11-8(6-12)7-13;7-5-2-1-4(9(10)11)3-6(5)8;2*1-2;;;;;;;;;/h3-8,11-13,19H,1,9-10,14-15H2,2H3,(H,31,37)(H2,30,32,33,34);4-5,8,12H,6-7,9-10H2,1-3H3;2-7H,1H2,(H,20,23)(H,19,21,22);2-3,6,10H,4-5,7-8H2,1H3;2-3,6,10H,4-5,7-8,13H2,1H3;1-2,5,9,12H,3-4,6-7H2;8,11,13H,4-7H2,1-3H3;1-3H;2*2H,1H3;2*1H4;1H3;5*1H2;/q;;;;;;;;;;;;-1;;;;;;/t19-;12-;;2*10-;9-;8-;;;;;;;;;;;;/m00.0000............/s1
InChIKeyJDMXCCPYFILJCN-QLVHGDCWSA-N
MW2688.38 g/mol
LogP18.53
Rot. Bonds15

About (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane

(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane (PubChem CID 159427083) has the molecular formula C112H154ClF8N26O20S6ScSe- and a molecular weight of 2688.38 g/mol. Its IUPAC name is (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane.

Molecular Properties

Compound Name(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane
PubChem CID159427083
Molecular FormulaC112H154ClF8N26O20S6ScSe-
Molecular Weight2688.38 g/mol
Exact Mass2686.84
IUPAC Name(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane
SMILESC.C.C=CC(=O)Nc1cccc(Nc2nc(Cl)ncc2C(F)(F)F)c1.C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)OC[C@@H]3CN(C)CCN43)ncc2C(F)(F)F)c1.CC(C)(C)OC(=O)N1CCN2c3ccc([N+](=O)[O-])cc3OC[C@@H]2C1.CC(C)(C)OC(=O)N1CCN[C@H](CO)C1.CN1CCN2c3ccc(N)cc3OC[C@@H]2C1.CN1CCN2c3ccc([N+](=O)[O-])cc3OC[C@@H]2C1.CS.C[SeH].O=[N+]([O-])c1ccc(F)c(F)c1.O=[N+]([O-])c1ccc2c(c1)OC[C@@H]1CNCCN21.S.S.S.S.S.[CH3-].[Sc]
InChIInChI=1S/C26H26F3N7O2.C16H21N3O5.C14H10ClF3N4O.C12H15N3O3.C12H17N3O.C11H13N3O3.C10H20N2O3.C6H3F2NO2.CH4S.CH4Se.2CH4.CH3.5H2S.Sc/c1-3-23(37)31-16-5-4-6-17(11-16)32-24-20(26(27,28)29)13-30-25(34-24)33-18-7-8-21-22(12-18)38-15-19-14-35(2)9-10-36(19)21;1-16(2,3)24-15(20)17-6-7-18-12(9-17)10-23-14-8-11(19(21)22)4-5-13(14)18;1-2-11(23)20-8-4-3-5-9(6-8)21-12-10(14(16,17)18)7-19-13(15)22-12;1-13-4-5-14-10(7-13)8-18-12-6-9(15(16)17)2-3-11(12)14;1-14-4-5-15-10(7-14)8-16-12-6-9(13)2-3-11(12)15;15-14(16)8-1-2-10-11(5-8)17-7-9-6-12-3-4-13(9)10;1-10(2,3)15-9(14)12-5-4-11-8(6-12)7-13;7-5-2-1-4(9(10)11)3-6(5)8;2*1-2;;;;;;;;;/h3-8,11-13,19H,1,9-10,14-15H2,2H3,(H,31,37)(H2,30,32,33,34);4-5,8,12H,6-7,9-10H2,1-3H3;2-7H,1H2,(H,20,23)(H,19,21,22);2-3,6,10H,4-5,7-8H2,1H3;2-3,6,10H,4-5,7-8,13H2,1H3;1-2,5,9,12H,3-4,6-7H2;8,11,13H,4-7H2,1-3H3;1-3H;2*2H,1H3;2*1H4;1H3;5*1H2;/q;;;;;;;;;;;;-1;;;;;;/t19-;12-;;2*10-;9-;8-;;;;;;;;;;;;/m00.0000............/s1
InChIKeyJDMXCCPYFILJCN-QLVHGDCWSA-N
XLogP18.53
TPSA519.87 Ų
H-Bond Donors10
H-Bond Acceptors39
Rotatable Bonds15
Heavy Atoms175
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002688.38
LogP ≤ 518.53
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1039

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}

Analyze (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane?
The IUPAC name of (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane (CID 159427083) is (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane.
What is the SMILES notation for (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane?
The canonical SMILES for (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane is C.C.C=CC(=O)Nc1cccc(Nc2nc(Cl)ncc2C(F)(F)F)c1.C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc4c(c3)OC[C@@H]3CN(C)CCN43)ncc2C(F)(F)F)c1.CC(C)(C)OC(=O)N1CCN2c3ccc([N+](=O)[O-])cc3OC[C@@H]2C1.CC(C)(C)OC(=O)N1CCN[C@H](CO)C1.CN1CCN2c3ccc(N)cc3OC[C@@H]2C1.CN1CCN2c3ccc([N+](=O)[O-])cc3OC[C@@H]2C1.CS.C[SeH].O=[N+]([O-])c1ccc(F)c(F)c1.O=[N+]([O-])c1ccc2c(c1)OC[C@@H]1CNCCN21.S.S.S.S.S.[CH3-].[Sc].
What is the InChIKey of (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane?
The InChIKey is JDMXCCPYFILJCN-QLVHGDCWSA-N. The full InChI is InChI=1S/C26H26F3N7O2.C16H21N3O5.C14H10ClF3N4O.C12H15N3O3.C12H17N3O.C11H13N3O3.C10H20N2O3.C6H3F2NO2.CH4S.CH4Se.2CH4.CH3.5H2S.Sc/c1-3-23(37)31-16-5-4-6-17(11-16)32-24-20(26(27,28)29)13-30-25(34-24)33-18-7-8-21-22(12-18)38-15-19-14-35(2)9-10-36(19)21;1-16(2,3)24-15(20)17-6-7-18-12(9-17)10-23-14-8-11(19(21)22)4-5-13(14)18;1-2-11(23)20-8-4-3-5-9(6-8)21-12-10(14(16,17)18)7-19-13(15)22-12;1-13-4-5-14-10(7-13)8-18-12-6-9(15(16)17)2-3-11(12)14;1-14-4-5-15-10(7-14)8-16-12-6-9(13)2-3-11(12)15;15-14(16)8-1-2-10-11(5-8)17-7-9-6-12-3-4-13(9)10;1-10(2,3)15-9(14)12-5-4-11-8(6-12)7-13;7-5-2-1-4(9(10)11)3-6(5)8;2*1-2;;;;;;;;;/h3-8,11-13,19H,1,9-10,14-15H2,2H3,(H,31,37)(H2,30,32,33,34);4-5,8,12H,6-7,9-10H2,1-3H3;2-7H,1H2,(H,20,23)(H,19,21,22);2-3,6,10H,4-5,7-8H2,1H3;2-3,6,10H,4-5,7-8,13H2,1H3;1-2,5,9,12H,3-4,6-7H2;8,11,13H,4-7H2,1-3H3;1-3H;2*2H,1H3;2*1H4;1H3;5*1H2;/q;;;;;;;;;;;;-1;;;;;;/t19-;12-;;2*10-;9-;8-;;;;;;;;;;;;/m00.0000............/s1.
What are the key properties of (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane?
(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane has a molecular weight of 2688.38 g/mol, XLogP of 18.53, 15 rotatable bonds, 10 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for (4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[3-[[2-[[(4aS)-3-methyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;(4aS)-3-methyl-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine;(4aS)-8-nitro-1,2,3,4,4a,5-hexahydropyrazino[2,1-c][1,4]benzoxazine;tert-butyl (4aS)-8-nitro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazine-3-carboxylate;tert-butyl (3S)-3-(hydroxymethyl)piperazine-1-carboxylate;carbanide;N-[3-[[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1,2-difluoro-4-nitrobenzene;methane;methaneselenol;methanethiol;scandium;sulfane is sourced from PubChem (CID 159427083), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).